Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.
M G
MG
Boyeson
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology*; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology*; D002561:Cerebrovascular Disorders / Q000150:complications / Q000503:physiopathology* / Q000534:rehabilitation; D016000:Cluster Analysis; D003863:Depression / Q000188:drug therapy* / Q000209:etiology; D005473:Fluoxetine / Q000494:pharmacology*; D006801:Humans; D008376:Maprotiline / Q000494:pharmacology*; D011597:Psychomotor Performance / Q000187:drug effects*; D012107:Research Design; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*
D018759:Adrenergic Uptake Inhibitors; D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine; D008376:Maprotiline; D017367:Selective Serotonin Reuptake Inhibitors